New study tests if adding a second release to carpal tunnel surgery boosts relief

NCT ID NCT07594821

Recruiting now Symptom relief Sponsor: Maasstad Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares standard carpal tunnel release surgery to an extended version that also releases a ligament in the forearm. Many people still have symptoms after standard surgery, possibly because the nerve is also compressed higher up. The trial will enroll 110 adults with carpal tunnel syndrome to see which approach provides better symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: surgery (carpal tunnel release with or without lacertus fibrosis release)
What this could lead to: If the extended surgery works better, it could reduce the number of people who still have symptoms after standard carpal tunnel release.
What could go wrong: This is a small, early-stage trial with only 110 participants. The extended surgery may not provide extra benefit and could carry additional risks like more scarring or longer recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARPAL TUNNEL SYNDROME (CTS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARPAL TUNNEL SYNDROME (CTS) LACERTUS SYNDROME

Contacts and locations

Locations

Maasstad Ziekenhuis
RECRUITING

Rotterdam, South Holland, 3079 DZ, Netherlands
Spijkenise Medisch Centrum
RECRUITING

Rotterdam, South Holland, 3201 GZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.